keyword
https://read.qxmd.com/read/38640509/a-commentary-on-circulating-25-hydroxyvitamin-d-concentration-can-predict-bowel-resection-risk-among-individuals-with-inflammatory-bowel-disease-in-a-longitudinal-cohort-with-13-years-of-follow-up
#1
JOURNAL ARTICLE
Biao Liang, Yiheng Yang, Wang Zhenyi
No abstract text is available yet for this article.
April 19, 2024: International Journal of Surgery
https://read.qxmd.com/read/38639899/surgical-management-of-duodenal-crohn-s-disease
#2
JOURNAL ARTICLE
Nicholas P McKenna, Katherine A Bews, Maxwell D Mirande, Franciso M Abarca Rendon, Asya Ofshteyn, Thomas Peponis, Sherief F Shawki, Scott R Kelley, Kellie L Mathis
BACKGROUND: Operative options for duodenal Crohn's disease include bypass, stricturoplasty, or resection. What factors are associated with operation selection and whether differences exist in outcomes is unknown. METHODS: Patients with duodenal Crohn's disease requiring operative intervention across a multi-state health system were identified. Patient and operative characteristics, short-term surgical outcomes, and the need for future endoscopic or surgical management of duodenal Crohn's disease were analyzed...
April 19, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38639677/aga-clinical-practice-update-on-pain-management-in-inflammatory-bowel-disease-commentary
#3
Laurie Keefer, Jana G Hashash, Eva Szigethy, Emeran A Mayer
DESCRIPTION: Pain is a common symptom among patients with inflammatory bowel disease (IBD). Although pain typically occurs during episodes of inflammation, it is also commonly experienced when intestinal inflammation is quiescent. Many gastroenterologists are at a loss how to approach pain symptoms when they occur in the absence of gut inflammation. We provide guidance in this area as to the evaluation, diagnosis, and treatment of pain among patients with IBD. METHODS: This CPU was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology...
April 17, 2024: Gastroenterology
https://read.qxmd.com/read/38638542/aetiologies-of-low-alkaline-phosphatase-in-a-canadian-paediatric-tertiary-care-centre
#4
JOURNAL ARTICLE
Anne Marie Sbrocchi, Rosalie Cavin, Annie Marleau, Tanya Fournier, Michael Beecroft, Beatriz Ferraz Dos Santos
OBJECTIVES: Increasingly, laboratories flag low serum alkaline phosphatase (sALP) that are age-and sex-specific in paediatrics. The aim of this study was to report clinical manifestations of paediatric patients with age-and sex-specific low sALP, thereby increasing awareness of its potential aetiologies. METHODS: This retrospective Canadian tertiary care paediatric hospital study assessed all sALP of ambulatory patients aged less than 18 years from 2015 to 2017...
December 2023: Paediatrics & Child Health
https://read.qxmd.com/read/38638444/evaluating-the-causal-association-between-bronchiectasis-and-different-types-of-inflammatory-bowel-disease-a-two-sample-mendelian-randomization-study
#5
JOURNAL ARTICLE
Qian Zeng, Da Hu, Yuan Li, Zhiwei Zhou, Jinfeng Wu, Xiaodong Li, Xiqiu Yu
BACKGROUND AND OBJECTIVES: Previous observational studies have established a connection between bronchiectasis and inflammatory bowel disease (IBD), but none of these studies have provided a clear explanation for the underlying cause of this relationship. The present study thus implemented Mendelian randomization (MR) design to explore possible bidirectional relationships between IBD and bronchiectasis risk, with an additional focus on Crohn's disease (CD) and ulcerative colitis (UC) as IBD subtypes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638365/development-of-ac2-26-mesoporous-microparticle-system-as-a-potential-therapeutic-agent-for-inflammatory-bowel-diseases
#6
JOURNAL ARTICLE
Milena Fronza Broering, Pedro Leonidas Oseliero Filho, Pâmela Pacassa Borges, Luis Carlos Cides da Silva, Marcos Camargo Knirsch, Luana Filippi Xavier, Pablo Scharf, Silvana Sandri, Marco Antonio Stephano, Fernando Anselmo de Oliveira, Ibrahim M Sayed, Lionel Fernel Gamarra, Soumita Das, Márcia C A Fantini, Sandra H P Farsky
INTRODUCTION: Inflammatory bowel diseases (IBDs) disrupt the intestinal epithelium, leading to severe chronic inflammation. Current therapies cause adverse effects and are expensive, invasive, and ineffective for most patients. Annexin A1 (AnxA1) is a pivotal endogenous anti-inflammatory and tissue repair protein in IBD. Nanostructured compounds loading AnxA1 or its active N-terminal mimetic peptides improve IBD symptomatology. METHODS: To further explore their potential as a therapeutic candidate, the AnxA1 N-terminal mimetic peptide Ac2-26 was incorporated into SBA-15 ordered mesoporous silica and covered with EL30D-55 to deliver it by oral treatment into the inflamed gut...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38638288/hypoxia-hypoxia-inducible-factors-and-inflammatory-bowel-diseases
#7
REVIEW
Fei Hou, Xixi Bian, Dehuai Jing, Huikuan Gao, Fengqin Zhu
Adequate oxygen supply is essential for maintaining the body's normal physiological function. In chronic inflammatory conditions such as inflammatory bowel disease (IBD), insufficient oxygen reaching the intestine triggers the regulatory system in response to environmental changes. However, the pathogenesis of IBD is still under investigation. Recent research has highlighted the significant role of hypoxia in IBD, particularly the involvement of hypoxia-inducible factors (HIF) and their regulatory mechanisms, making them promising therapeutic targets for IBD...
2024: Gastroenterology Report
https://read.qxmd.com/read/38638204/isolated-celiac-artery-vasculitis-presenting-as-ileus-in-a-patient-with-ulcerative-colitis
#8
Sareena Ali, Meghana Doniparthi, Nahren Asado, Kristina Borgen, Alan Shapiro
There is a known association between inflammatory bowel disease (IBD) and vasculitis, which can present with mesenteric ischemia or cutaneous manifestations. Infliximab, an anti-tumor necrosis factor (anti-TNF) used to treat IBD, has been implicated as a potential culprit. We present a unique case of a patient with ulcerative colitis who developed isolated celiac artery vasculitis presenting with abdominal pain and ileus after decreasing his dosage of azathioprine. Vasculitis resolved with steroids and increasing azathioprine dosage, while continuing anti-TNF therapy, suggesting that anti-TNF agents are not the only cause of vasculitis in patients with IBD or that thiopurines may be protective...
April 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38638203/refractory-ulcerative-colitis-with-associated-synovitis-acne-pustulosis-hyperostosis-osteitis-syndrome-successfully-treated-with-tofacitinib
#9
Bryan J Kim, Anna Thiemann, Brett Dietz, Kendall Beck
Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome is a rare inflammatory condition associated with inflammatory bowel disease. Limited data exist on standardized management. We report a case of refractory SAPHO syndrome and ulcerative colitis (UC) treated successfully with tofacitinib. A 54-year-old man with UC presented with an intractable headache. A diagnosis of SAPHO syndrome was made based on the finding of sterile osteitis in the skull base and persistent severe UC. Symptoms, imaging, and endoscopy revealed persistent UC and osteitis despite multiple therapies...
April 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38638127/precision-medicine-in-inflammatory-bowel-disease
#10
REVIEW
Zhen Zeng, Mingshan Jiang, Xi Li, Jing Yuan, Hu Zhang
Inflammatory bowel disease (IBD) is an incurable disease characterized by remission-relapse cycles throughout its course. Both Crohn's disease (CD) and ulcerative colitis (UC), the two main forms of IBD, exhibit tendency to develop complications and substantial heterogeneity in terms of frequency and severity of relapse, thus posing great challenges to the clinical management for IBD. Current treatment strategies are effective in different ways in induction and maintenance therapies for IBD. Recent advances in studies of genetics, pharmacogenetics, proteomics and microbiome provide a strong driving force for identifying molecular markers of prognosis and treatment response, which should help clinicians manage IBD patients more effectively, and then, improve clinical outcomes and reduce treatment costs of patients...
December 2023: Precision Clinical Medicine
https://read.qxmd.com/read/38637862/short-chain-fatty-acid-producing-bacterial-strains-attenuate-experimental-ulcerative-colitis-by-promoting-m2-macrophage-polarization-via-jak-stat3-foxo3-axis-inactivation
#11
JOURNAL ARTICLE
Hailan Zhao, Youlian Zhou, Jing Xu, Yong Zhang, Hong Wang, Chong Zhao, Hongli Huang, Jing Yang, Chen Huang, Yingfei Li, Lisheng Wang, Yuqiang Nie
BACKGROUND: Patients with inflammatory bowel disease (IBD), dysbiosis, and immunosuppression who receive fecal microbiota transplantation (FMT) from healthy donors are at an increased risk of developing bacteremia. This study investigates the efficacy of a mixture of seven short-chain fatty acid (SCFA)-producing bacterial strains (7-mix), the resulting culture supernatant mixture (mix-sup), and FMT for treating experimental ulcerative colitis (UC) and evaluates underlying mechanisms. METHODS: Utilizing culturomics, we isolated and cultured SCFA-producing bacteria from the stool of healthy donors...
April 18, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38637733/helminth-derived-proteins-as-immune-system-regulators-a-systematic-review-of-their-promise-in-alleviating-colitis
#12
JOURNAL ARTICLE
Maimonah Alghanmi, Faisal Minshawi, Tarfa A Altorki, Ayat Zawawi, Isra Alsaady, Abdallah Y Naser, Hassan Alwafi, Soa'ad M Alsulami, Ala A Azhari, Anwar M Hashem, Rowa Alhabbab
Helminth-derived proteins have immunomodulatory properties, influencing the host's immune response as an adaptive strategy for helminth survival. Helminth-derived proteins modulate the immune response by inducing anti-inflammatory cytokines, promoting regulatory T-cell development, and ultimately favouring a Th2-biased immune response. This systematic review focused on helminth-derived proteins and explored their impact on reducing inflammatory responses in mouse models of colitis. A systematic search across Medline, EMBASE, Web of Science, and Cochrane Library identified fourteen relevant studies...
April 18, 2024: BMC Immunology
https://read.qxmd.com/read/38637459/psychological-care-for-people-with-inflammatory-bowel-diseases-exploring-consumers-perspectives-to-inform-future-service-co-design
#13
JOURNAL ARTICLE
Taryn Lores, Antonina Mikocka-Walus, Jane M Andrews, Subhadra Evans, Kate D Lynch, Anna Chur-Hansen
BACKGROUND: There is a need to improve psychological care for people with Inflammatory Bowel Diseases (IBD), noting the high psychosocial burden of disease. AIMS: This study qualitatively explored the views of people living with IBD to help inform future co-design of services that better meet the psychological needs of consumers. METHODS: Adults with IBD were recruited to attend virtual focus groups to discuss what they want most in an IBD-specific psychological service...
April 18, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38637457/real-world-outcomes-of-patients-starting-intravenous-and-transitioning-to-subcutaneous-vedolizumab-in-inflammatory-bowel-disease
#14
JOURNAL ARTICLE
N Lamichhane, N Melas, V Bergqvist, N-P Ekholm, O Olén, J F Ludvigsson, H Hjortswang, J Marsal, C Eriksson, J Halfvarson
BACKGROUND: Real-world data on starting intravenous (IV) vedolizumab (VDZ) and transitioning to subcutaneous (SC) treatment in inflammatory bowel disease (IBD) are scarce. AIMS: To assess treatment outcomes of patients with IBD starting IV VDZ and switching to SC VDZ in routine clinical care. METHODS: Adult patients with IBD switching from IV to SC VDZ treatment between 1 March 2020 and 31 December 2021 were identified from the Swedish IBD quality register...
April 18, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38637195/inflammatory-causes-of-dysphagia-in-children
#15
REVIEW
Marisa A Ryan, Anna Ermarth
Gastroesophageal reflux (GER) and eosinophilic esophagitis (EoE) are the most common inflammatory causes of pediatric dysphagia, but several other less prevalent conditions should be considered. These conditions can affect one or several aspects of the swallowing process. In some inflammatory conditions dysphagia may be an early symptom. Esophagoscopy and instrumental swallow studies are often needed to determine the underlying diagnosis and best treatment plan. In some inflammatory conditions dysphagia can portend a worse outcome and need for more aggressive treatment of the underlying condition...
April 17, 2024: Otolaryngologic Clinics of North America
https://read.qxmd.com/read/38636749/an-inulin-based-glycovesicle-for-pathogen-targeted-drug-delivery-to-ameliorate-salmonellosis
#16
JOURNAL ARTICLE
Yujie Xu, Congmin Niu, Shuyi Liang, Jiayi Guo, Kaiming Li, Jiarui Zhang, Jingyuan Li, Yaju Jin, Jingkun Bai, Jiangkun Dai, Chunbo Lu
The gut microbiota plays a significant role in the pathogenesis and remission of inflammatory bowel disease. However, conventional antibiotic therapies may alter microbial ecology and lead to dysbiosis of the gut microbiome, which greatly limits therapeutic efficacy. To address this challenge, novel nanomicelles that couple inulin with levofloxacin via disulfide bonds for the treatment of salmonellosis were developed in this study. Owing to their H2 S-responsiveness, the nanomicelles can target the inflamed colon and rapidly release levofloxacin to selectively fight against enteric pathogens...
April 16, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38635882/exploring-the-predictive-value-of-gut-microbiome-signatures-for-therapy-intensification-in-patients-with-inflammatory-bowel-disease-a-10-year-follow-up-study
#17
JOURNAL ARTICLE
Zainab M A Al Radi, Femke M Prins, Valerie Collij, Arnau Vich Vila, Eleonora A M Festen, Gerard Dijkstra, Rinse K Weersma, Marjolein A Y Klaassen, Ranko Gacesa
BACKGROUND: Inflammatory bowel diseases (IBDs) pose a significant challenge due to their diverse, often debilitating, and unpredictable clinical manifestations. The absence of prognostic tools to anticipate the future complications that require therapy intensification presents a substantial burden to patient private life and health. We aimed to explore whether the gut microbiome is a potential biomarker for future therapy intensification in a cohort of 90 IBD patients. METHODS: We conducted whole-genome metagenomics sequencing on fecal samples from these patients, allowing us to profile the taxonomic and functional composition of their gut microbiomes...
April 18, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38635881/erratum
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 18, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38635299/avoidant-restrictive-food-intake-disorder-symptoms-are-not-as-frequent-as-other-eating-disorder-symptoms-when-ulcerative-colitis-is-in-remission
#19
JOURNAL ARTICLE
Helen Burton-Murray, Katheryn Kiser, Jenny Gurung, Katherine Williams, Jennifer J Thomas, Hamed Khalili
BACKGROUND AND AIM: Recent studies have shown that up to 53% of patients with inflammatory bowel disease (IBD) screen positive for avoidant/restrictive food intake disorder (ARFID). There is however concern that ARFID screening rates are over-inflated in patients with active disease. We aimed to evaluate the frequency and characteristics of ARFID symptoms using the Nine Item ARFID Screen (NIAS), and to use another eating disorder measure, the Eating Disorder Examination-Questionnaire 8 (EDE-Q8), to rule-out/characterize other eating disorder cognitive and behavioral symptoms...
April 18, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38635139/inflammatory-gene-panel-guiding-the-study-of-genetics-in-inflammatory-bowel-disease
#20
REVIEW
Ryan Xin
Inflammatory bowel disease (IBD) is a complex disease that develops through a sequence of molecular events that are still poorly defined. This process is driven by a multitude of context-dependent genes that play different roles based on their environment. The complexity and multi-faceted nature of these genes make it difficult to study the genetic basis of IBD. The goal of this article is to review the key genes in the pathophysiology of IBD and highlight new technology that can be used in further research...
April 18, 2024: Molecular Diagnosis & Therapy
keyword
keyword
833
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.